Hains, Isla http://orcid.org/0000-0001-9041-8627
Meyers, Josh
Sterling, Kirsten
Yoo, Jeannie
Reddel, Helen
Weston, Clare
Funding for this research was provided by:
AstraZeneca Australia
Novartis Pharmaceuticals Australia Pty Ltd
Article History
Received: 19 February 2019
Accepted: 8 July 2019
First Online: 13 July 2019
Ethics approval and consent to participate
: Ethics approval for the questionnaire, and its amendment following the change to data collection, was obtained from the Royal Australian College of General Practitioners National Research and Evaluation Ethics Committee (NREEC 17–018). GPs were provided with an information sheet that explained the study and highlighted that survey completion implied consent. Written consent to participate was therefore not obtained from participating GPs.
: Not applicable.
: Author HR or her institute have received honoraria for providing independent advice on advisory boards, steering committees and data safety monitoring board for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck and Novartis; independent consulting for AstraZeneca and GlaxoSmithKline; for providing independent medical education at symposia funded by AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mundipharma, Novartis and Teva. Her institute has received independent research grants from AstraZeneca and GlaxoSmithKline. She has participated in a Novartis-funded severe asthma registry study.